awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33397131-844E73D5-2438-4D56-A78E-20960D927542
Q33397131-844E73D5-2438-4D56-A78E-20960D927542
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33397131-844E73D5-2438-4D56-A78E-20960D927542
A phase I-II study of elacytarabine (CP-4055) in the treatment of patients with ovarian cancer resistant or refractory to platinum therapy.
P2860
Q33397131-844E73D5-2438-4D56-A78E-20960D927542
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33397131-844E73D5-2438-4D56-A78E-20960D927542
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8e81644fc35b00d657b71d050e065d42f7329072
P2860
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada